Because the market never under values shares?? That woukd make vakue investing a pretty difficult way to make money if that were the case. Have a look at comparable companies in the USA. Most biotech companies there have significantly higher valuations despite having nowhere near the potential market our drugs could have. The risk/reward ratio is heavily skewed to the reward side for IMU, IMO only of course.
Add to My Watchlist
What is My Watchlist?
